Menu Search
Equities

Zepp Health Corp

ZEPPN:MEX

Zepp Health Corp

Actions
  • Price (MXN)104.53
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 20 minutes, as of Jan 19 2022 11:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zepp Health Corp, formerly Huami Corp, is a company committed to connect health with technology. It has developed a platform of proprietary technology including artificial intelligence (AI) chips, biometric sensors, and health data algorithms. It is engaged in developing smart wearable technology. It designs and develops biometric and activity data-driven fitness and smart watches. It markets its products under the brand name, Amazfit and is the sole partner for Xiaomi wearable products. The products includes Amazfit BIP, Amazfit pace, Amazfit equator, Amazfit ARC, and accessories, such as sports bands, watch straps, ear buds, charging units, and core trackers. The smart watches provides activity tracking, sleep tracking, smart notifications from mobile devices, GPS, heart rate sensing, water resistance, wireless syncing with mobile phones. It also provides a mobile application to keep track of the fitness information, set alarms and receive call notifications on the smart watch.

  • Revenue in USD (TTM)345.70m
  • Net income in USD-29.39m
  • Incorporated2014
  • Employees839.00
  • Location
    Zepp Health CorpBuilding B2, Zhong'an ChuangguTechnology Park, No.900 Wangjiang WestRdHEFEI 230088ChinaCHN
  • Phone+86 55 165837200
  • Websitehttp://www.huami.com
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.